Biocon gets notice of compliance from Health Canada for two biosimilars
Summary
Biocon receives Health Canada's compliance notice for biosimilars Bosaya and Vevzuo, enhancing treatment options for osteoporosis and cancer.
Description
Biocon receives Health Canada's compliance notice for biosimilars Bosaya and Vevzuo, enhancing treatment options for osteoporosis and cancer.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source